Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Guardant Health Inc (GH)
Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,037,114
  • Shares Outstanding, K 117,992
  • Annual Sales, $ 449,540 K
  • Annual Income, $ -654,590 K
  • 60-Month Beta 0.90
  • Price/Sales 6.89
  • Price/Cash Flow N/A
  • Price/Book 13.27
Trade GH with:

Options Overview Details

View History
  • Implied Volatility 54.48% ( -0.57%)
  • Historical Volatility 64.83%
  • IV Percentile 22%
  • IV Rank 5.31%
  • IV High 207.05% on 12/14/22
  • IV Low 45.92% on 09/14/23
  • Put/Call Vol Ratio 2.41
  • Today's Volume 191
  • Volume Avg (30-Day) 706
  • Put/Call OI Ratio 0.52
  • Today's Open Interest 22,541
  • Open Int (30-Day) 19,830

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.85
  • Number of Estimates 6
  • High Estimate -0.53
  • Low Estimate -1.01
  • Prior Year -1.36
  • Growth Rate Est. (year over year) +37.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.19 +21.47%
on 11/10/23
27.54 -6.54%
on 12/04/23
+2.07 (+8.77%)
since 11/08/23
3-Month
21.19 +21.47%
on 11/10/23
34.66 -25.74%
on 09/11/23
-7.98 (-23.67%)
since 09/08/23
52-Week
20.67 +24.53%
on 04/27/23
50.11 -48.63%
on 12/13/22
-21.61 (-45.64%)
since 12/08/22

Most Recent Stories

More News
Guardant Health: Q3 Earnings Snapshot

Guardant Health: Q3 Earnings Snapshot

GH : 25.74 (-1.98%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

EQNX::TICKER_START (OTCQB:TDSGF),(TSXV:TELO),(NASDAQ:GH),(NASDAQ:NTRA),(NYSE:DGX),(NASDAQ:NEO) EQNX::TICKER_END

TDSGF : 0.1309 (-8.33%)
TELO.VN : 0.170 (-5.56%)
GH : 25.74 (-1.98%)
NTRA : 58.15 (+0.36%)
DGX : 135.91 (+0.51%)
NEO : 18.34 (+2.23%)
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030

/PRNewswire/ -- Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight...

TELO.VN : 0.170 (-5.56%)
TDSGF : 0.1309 (-8.33%)
GH : 25.74 (-1.98%)
NTRA : 58.15 (+0.36%)
DGX : 135.91 (+0.51%)
NEO : 18.34 (+2.23%)
1 Beaten-Down Healthcare Stock to Buy and Hold For 10 Years

This company's fight against a deadly disease could pay off.

GH : 25.74 (-1.98%)
Which Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?

The oncology diagnostic companies are looking for better solutions in early cancer diagnosis.

EXAS : 64.72 (-0.37%)
GH : 25.74 (-1.98%)
Why Guardant Health Stock Jumped 15% This Week

The precision oncology leader benefited from a pair of positive analyst notes this week. Here's what investors need to know.

GH : 25.74 (-1.98%)
Why Guardant Health Stock Popped Again Today

Wall Street loves this unprofitable biotech.

GH : 25.74 (-1.98%)
Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases

/PRNewswire/ -- USA News Group - The seriousness of pancreatic cancer continues to grow, with increasing alarm since The Lancet published an analysis back in...

ONC.TO : 1.90 (-0.52%)
ONCY : 1.4000 (unch)
MRUS : 23.93 (-3.35%)
GH : 25.74 (-1.98%)
MDT : 79.35 (-0.25%)
NVDA : 475.06 (+1.95%)
Pancreatic Cancer Research Gains Momentum Amidst Soaring Young-Onset Cases

FN Media Group Presents USA News Group News Commentary   Vancouver, BC – September 26, 2023 – USA News Group  –  The seriousness of pancreatic cancer continues to grow, with increasing alarm since...

ONCY : 1.4000 (unch)
ONC.TO : 1.90 (-0.52%)
MRUS : 23.93 (-3.35%)
GH : 25.74 (-1.98%)
MDT : 79.35 (-0.25%)
NVDA : 475.06 (+1.95%)
Pancreatic Cancer's Alarming Surge in Young Adults Sparks Research into New Treatments

USA News Group – The seriousness of pancreatic cancer continues to grow, with increasing alarm since The Lancet published an analysis back in April 2023, showing a rising incidence of pancreatic cancer...

ONCY : 1.4000 (unch)
ONC.TO : 1.90 (-0.52%)
MRUS : 23.93 (-3.35%)
GH : 25.74 (-1.98%)
MDT : 79.35 (-0.25%)
NVDA : 475.06 (+1.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Guardant Health Inc. is a precision oncology company. It focuses on conquer cancer through use of proprietary blood tests, vast data sets and advanced analytics. The company's Guardant Health Oncology Platform is designed for clinical development, regulatory and reimbursement to drive commercial adoption,...

See More

Key Turning Points

3rd Resistance Point 26.75
2nd Resistance Point 26.41
1st Resistance Point 26.07
Last Price 25.74
1st Support Level 25.39
2nd Support Level 25.05
3rd Support Level 24.71

See More

52-Week High 50.11
Fibonacci 61.8% 38.86
Fibonacci 50% 35.39
Fibonacci 38.2% 31.92
Last Price 25.74
52-Week Low 20.67

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar